Harry L. Leider - 06 Jun 2023 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role: CEO and Director, Director
Signature: /s/ Harry Leider
Issuer symbol: OCEL
Transactions as of: 06 Jun 2023
Net transactions value: $0
Form type: 3
Filing time: 09 Jun 2023, 16:35:15 UTC
Previous filing: 09 May 2022
Next filing: 30 Jun 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	OCEL	Options to Purchase Common Stock							06 Jun 2023	Common Stock, par value $0.001 per share	57,000,000	$0.0120	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an option to purchase common stock granted to the Reporting Person on June 6, 2023 under the issuer's Equity Incentive Plan (the "Plan"). The option vests in equal quarterly installments over a three-year period from the date of grant, is contingent upon the Reporting Person's continued employment by the issuer and is otherwise subject to the terms and conditions of the Plan. In the event of a "change in control" or the achievement of certain milestones, vesting of the option may be accelerated.

Content

Represents an option to purchase common stock granted to the Reporting Person on June 6, 2023 under the issuer's Equity Incentive Plan (the "Plan"). The option vests in equal quarterly installments over a three-year period from the date of grant, is contingent upon the Reporting Person's continued employment by the issuer and is otherwise subject to the terms and conditions of the Plan. In the event of a "change in control" or the achievement of certain milestones, vesting of the option may be accelerated.